Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines

Anti-Cancer Drugs

Volumn 8, Issue 5, 1997, Pages 470-481

  Mehta, Kapil ^a   Pantazis, Panayotis ^c   McQueen, Theresa ^a   Aggarwal, Bharat B ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c Stehlin Found for Cancer Research   (United States)

Author keywords

Breast carcinoma; Cell cycle; Drug resistance; Flavonoids; Ornithine deoxycarboxylase

Indexed keywords

CURCUMIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; DRUG EFFECT; EXPRESSION VECTOR; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HUMAN; PRIORITY JOURNAL;

EID: 0030872976     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199706000-00010     Document Type: Article

References (47)

1. Huang M-T, Wang ZY, Georgiadis CA, Laskin JD, Conney AH. Inhibitory effects of curcumin on tumor initiation by benzo[a]pyrene and 7,12-dimethylbenz-[a]anthracene. Carcinogenesis 1992; 13: 2183z-6.
2. Azuine MA, Bhide SV. Chemopreventive effect of tumeric against stomach and skin tumors induced by chemical carcinogens in swiss mice. Nutr Cancer 1992; 17: 77-83.
3. Azuine MA, Bhide SV. Protective single/combined treatment with betel leaf and turmeric against methyl (acetoxymethyl) nitrosamine-induced hamster oral carcinogenesis. Int J Cancer 1992; 51: 412-5.
4. Nagabhushan M, Bhide SV. Curcumin as an inhibitor of cancer. J Am Coll Nutr 1992; 11: 192-8.
5. Huang M-T, Smart RC, Wong C-Q, Conney AH. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 1988; 48: 5941-6.
6. Conney AH, Lysz T, Ferraro T, et al. Inhibitory effect of curcumin and some related dietary compounds on tumor promotion and arachidonic acid metabolism in mouse skin. Adv Enzyme Regul 1991; 31: 385-96.
7. Ammon HP, Wahl MA. Pharmacology of Curcuma longa. Plant Med 1991; 57: 1-7.
8. Satoskar RR, Shah SJ, Shenoy SG. Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. Int J Clin Pharmacol 1986; 24: 651-4.
9. Shankar TNB, Shantha NV, Ramsh HP, Murthy IAS, Murthy VS. Toxicity studies on turmeric (Curcuma longa): acute toxicity studies in rats, guinea pigs and monkeys. Indian J Exp Biol 1980; 18: 73-5.
10. Srivastava R. Inhibition of neutrophil response by curcumin. Agents Action 1989; 38: 298-303.
11. Huang H-C, Jan T-R, Yeh S-F. Inhibitory effect of curcumin, an anti-inflammatory agent, on vascular smooth muscle cell proliferation. Eur J Pharmacol 1992; 221: 381-4.
12. Shalini VK, Srinivas L. Lipid peroxide induced DNA damage: protection by turmeric (Curcuma longa). Mol Cell Biol 1987; 77: 3-10.
13. Unnikrishnan MK, Rao MNA. Curcumin inhibits nitrite-induced methemoglobin formation. FEBS Lett 1992; 301: 195-6.
14. Donatus IA, Vermeulen S, Vermeulen NPE. Cytotoxic and cytoprotective activities of curcumin. Biochem Pharmacol 1990; 39: 1869-75.
15. Shalini VK, Srinival L. Fuel smoke condensate induced DNA damage in human lymphocytes and protection by tumeric (Curcuma longa). Mol Cell Biol 1990; 95: 21-30.
16. Huang T-S, Lee S-C, Lin J-K. Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proc Natl Acad Sci USA 1991; 88: 5292-6.
17. Singh S, Aggarwal BB. Activation and transcription factor NF-κB is suppressed by curcumin. J Biol Chem 1995; 270: 24995-5000.
18. Liu J-Y, Ju S, Lin-J-K. Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol-13 acetate in NIH 3T3 cells. Carcinogenesis 1993; 14: 857-61.
19. Lin JK, Shih CA. Inhibitory effect of curcumin on xanthine dehydrogenase/oxidase induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH3T3 cells. Carcinogenesis 1994; 15: 1717-21.
20. Rao CV, Simi B, Reddy BS. Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, and arachidonic acid metabolism and aberrant crypt foci formation in rat colon. Carcinogenesis 1993; 14: 2219-25.
21. Reddy S, Aggarwal BB. Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase. FEBS Lett 1994; 341: 19-22.
22. Korutla L, Kumar R. Inhibitory effect of curcumin on epidermal growth factor receptor kinase activity in A431 cells. Biochem Biophys Acta 1994; 1224: 597-600.
23. Korutla L, Cheung JY, Mendelsohn J, Kumar R. Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin. Carcinogenesis 1995; 16: 1741-5.
24. Mehta K. High levels of transglutaminase expression in doxorubicin-resistant human breast carcinoma cells. Int J Cancer 1994; 58: 400-6.
25. Sugarman BJ, Aggarwal BB, Hass PE, Figari IS, Palladino MA, Shepard HM. Recombinant human tumor necrosis factor: Effects on proliferation of normal and transformed cells in vitro. Science 1985; 230: 943-5.
26. Vilcek J, Palombella VJ, Henriksen-DeStefano D, et al. Fibroblasts growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. J Exp Med 1986; 163: 632-43.
27. Grewal HS, Sloan D, Sampliner RE, Fennerty B. Ornithine decarboxylase assay in human colorectal mucosa. Methodologic issues of importance to quality control. Int J Cancer 1992; 52: 355-8.
28. Bouvier G, Hergenhahn M, Polack A, Bornkamm GW, Bartsch H. Validation of two test systems for detecting tumor promoting EBV inducers: chemopreventive responses of several agents in DR-CAT Raji cells and in human granulocytes. Carcinogenesis 1993; 14: 1573-8.
29. Li CJ, Zhang LJ, Dezube BJ, Crumpacker CS, Pardee AB. Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication. Proc Natl Acad Sci USA 1993; 90: 1839-42.
30. Kumar R, Atlas I. Interferon-α the expression of retinoblastoma gene product in human Burkitt's lymphoma Daudi cells: role in growth regulation. Proc Natl Acad Sci USA 1992; 89: 6599-603.
31. Massague J, Cheifetz S, Lahio M, Ralph DA, Weis FMB, Zentalla A. Transforming growth factor-β. In: Levine AJ, ed. Tumor suppressor genes, the cell cycle and cancer. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press 1992; 81-103.
32. cdc2 in mammalian cells: implication for cell cycle control and oncogenesis. Oncogene 1990; 5: 795-801.
33. Lin BT, Gruenwald SD, Marla A, Lee W-H, Wang JY. Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc kinase. EMBO J 1991; 10: 857-64.
34. Kohn KW, Jackman J, O'Conner PM. Cell cycle control and chemotherapy. J Cell Biochem 1994; 54: 440-52.
35. Heby O, Persson L. Molecular genetics of polyamine synthesis in eukaryotic cells. Trends Biochem Sci 1990; 172: 153-8.
36. Hayashi S-I. Ornithine decarboxylase: biology, enzymology, and molecular genetics. New York: Pergamon Press 1989.
37. Verma AK, Boutwell RK. Inhibition of carcinogenesis by inhibitors of putrescine biosynthesis. In: McCann PP, Pegg AE, Sjoerdsma A, eds. Inhibition of polyamine metabolism: biological significance and basis for new therapies. New York: Academic Press 1987 249-275.
38. Lee SA, Karaszkiewicz JW, Anderson WB. Elevated level of nuclear protein kinase C in multidrug-resistant MCF-7 human breast carcinoma cells. Cancer Res 1996; 52: 3750-3759.
39. Fine RL, Patel J, Chabner BA. Phorbol ester induce multidrug resistance in human breast cancer cells. Proc Natl Acad Sci USA 1988; 85: 582-6.
40. Ali-Osman F, Stein DE, Renwick A. Glutathione content and glutathione-S-transferase expression in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human malignant astrocytoma cell lines. Cancer Res 1990; 50: 6976-80.
41. 2. J Clin Invest 1992; 89: 794-802.
42. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-κB. Annu Rev Cell Biol 1994; 10: 405-55.
43. Wu M, Lee H, Bellas RE, et al. Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J 1996; 15: 4682-90.
44. Begg AA, Baltimore D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 1996; 247: 782-4.
45. Wang C-Y, Mayo MW, Baldwin AS, Jr. TNF and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 1996; 247: 784-7.
46. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNF-α-induced apoptosis by NF-κB. Science 1996; 247: 787-9.
47. Liu Z-G, Hsu H, Goeddel DV, Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 1996; 87: 565-76.